Navigation Links
Alimera Sciences Reports First Quarter 2013 Financial Results
Date:5/9/2013

ithin the meaning of the Private Securities Litigation Reform Act of 1995, regarding, among other things, Alimera's commercial plans for ILUVIEN in Germany, the United Kingdom and France and the regulatory status of ILUVIEN in the United States. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual results to differ materially from those projected in its forward-looking statements. Meaningful factors which could cause actual results to differ include, but are not limited to, uncertainty as to Alimera's ability to commercialize, and market acceptance of, ILUVIEN in the EU, as well as other factors discussed in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of Alimera's Annual Report on Form 10-K for the year ended December 31, 2012, which is on file with the Securities and Exchange Commission (SEC) and available on the SEC's website at www.sec.gov. Additional factors may also be set forth in those sections of Alimera's Quarterly Report on Form 10-Q for the quarter ended March 31, 2013 to be filed with the SEC in the second quarter of 2013. In addition to the risks described above and in Alimera's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings with the SEC, other unknown or unpredictable factors also could affect Alimera's results. There can be no assurance that the actual results or developments anticipated by Alimera will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, Alimera. Therefore, no assurance can be given that the outcomes stated in such forward-looking statements and estimates will be achieved.

All forward-looking statements contained in this press release are expressly qualifie
'/>"/>

SOURCE Alimera Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Alimera Sciences Secures $20 Million Debt Facility
2. Alimera Sciences To Release First Quarter Fiscal Year 2013 Financial Results
3. Alimera Sciences Reports Fourth Quarter 2012 Financial Results
4. Alimera Sciences To Release Fourth Quarter And Fiscal Year 2012 Financial Results
5. Alimera Sciences Participating in Credit Suisse London One-on-One Healthcare Conference
6. Alimera Sciences Names European Management Team
7. Alimera Sciences To Present At Credit Suisse 2012 Healthcare Conference
8. Alimera Sciences To Present At 2012 Stifel Nicolaus Healthcare Conference
9. Sangamo BioSciences Reports First Quarter 2013 Financial Results
10. Instrumentation Laboratory Awarded Massachusetts Life Sciences Center Tax Incentive
11. BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... the Netherlands , May 5, ... developing lower esophageal sphincter (LES) stimulation therapy for ... safety and efficacy results. The results demonstrated an ... and regurgitation and the "gold-standard" esophageal acid exposure ... elimination of dependence on daily PPI medications. ...
(Date:5/5/2015)... LYME, Conn. , May 5, 2015  American ... lab equipment in North America, has named industry veteran ... of Business Development. Becorest will be based out of ... where her role will include expanding the company,s west ... strategic partnership opportunities. "ALT has been the ...
(Date:5/5/2015)... -- IQPC,s 19 th Software Design for Medical Devices ... Summit Mr. Phani Bidarahalli , GM & Head of ... expert speaker faculty including senior executive from GE Healthcare, Philips ... The Hotel Kabuki in San Francisco . ... the event website, which can be accessed by visiting ...
Breaking Medicine Technology:Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 2Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 3ALT Names Anggie Becorest Senior Vice President of Business Development 2Phani Bidarahalli from Wipro to chair the upcoming 19th Software Design for Medical Devices Summit in San Francisco 2
... ROCKVILLE, Md., Oct. 24, 2011 Vanda Pharmaceuticals Inc. ... has named Bob Repella as Senior Vice President, Chief ... has more than 25 years of experience in the ... sales, new product development and commercial operations.   ...
... 24, 2011 Pinnacle Biologics, Inc., a privately held ... an Orphan Drug Designation (ODD) for their product PHOTOFRIN® ... in the treatment of Malignant Pleural Mesothelioma. ... the lining of the lungs. It is a rare, ...
Cached Medicine Technology:Vanda Pharmaceuticals Appoints Chief Commercial Officer 2Pinnacle Biologics Files for Orphan Drug Designation for PHOTOFRIN® in the Treatment of Patients with Malignant Mesothelioma. 2Pinnacle Biologics Files for Orphan Drug Designation for PHOTOFRIN® in the Treatment of Patients with Malignant Mesothelioma. 3Pinnacle Biologics Files for Orphan Drug Designation for PHOTOFRIN® in the Treatment of Patients with Malignant Mesothelioma. 4
(Date:5/5/2015)... California (PRWEB) May 05, 2015 On ... Downtown Los Angeles, CA, Choices Recovery sponsored Durkin Entertainment’s ... Durkin, LA’s leading producer of sustainable product placement in ... of the world’s top providers of ecologically sound and ... a premier red carpet event that makes appearances at ...
(Date:5/5/2015)... Oklahoma (PRWEB) May 05, 2015 Don’t ... the money for a fitness membership? Don’t know which ... of these obstacles in order to help members achieve ... life. Live Streaming Fitness, an educational, caused-based wellness company, ... offers live streaming fitness classes led by certified trainers, ...
(Date:5/5/2015)... Major League Ultimate (MLU) was founded by ... Frisbee™ is home to many amazing athletes, dramatic moments, ... world. Nike Ultimate Camps’ goal of spreading the sport ... athletes to learn about the sport and develop their ... , The Nike Ultimate Camp in Philadelphia by MLU ...
(Date:5/5/2015)... Igantia , an emerging biotechnology ... international initiative to examine key biological milestones during a ... Scientists at Igantia believe that better understanding of ... of her menstrual cycle to her transition into menopause, ... ultimately, extend the lifespan. , By recently announcing ...
(Date:5/5/2015)... After record-breaking sales of Extend Nutrition’s ... Cookies & Cream flavor at stores nationwide this month. ... raised the bar for nutritional snacks. The brand ... nutritional profile, backed by international patents and clinical studies. ... additional new products and expand retail availability throughout 2015. ...
Breaking Medicine News(10 mins):Health News:Choices Recovery Mishawaka Talks About Overcoming Adversity with Actor Matthew Ziff at the “RockNRolla Movie Awards” EcoLuxe Lounge 2Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 2Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 3Health News:US Sports Camps, Nike Ultimate Camps, and Major League Ultimate Host Youth Ultimate Summer Camps in Philidelphia 2Health News:Igantia Announces Digital Initiative to Decode Longevity 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4
... BIRMINGHAM, Ala., May 8 HealthSouth,Corporation (NYSE: HLS ... among other things, elect directors and provide an update ... May 2007., More than 88.5% of the outstanding ... in person or by proxy and the board,s,nominated slate ...
... NutraCea (OTC Bulletin Board:,NTRZ), a world leader in ... today that it will release its first quarter,financial ... closes., Management will host the conference call ... the first quarter financial results for 2008 and ...
... Shortly after the gruesome,discovery of aborted babies in ... early March, Citizens for a Pro-Life Society,discovered the mutilated ... Clinic in Livonia, Michigan, owned by Dr. Reginald Sharpe., ... in which we live that we,must stop and take ...
... Healthcare ... Reforms - ,Medicare for All, OAKLAND, Calif., ... America -- and the nation,s largest union of RNs,-- Bill ... fight for guaranteed,single-payer healthcare in an episode scheduled to air ...
... death, study finds , , THURSDAY, May 8 (HealthDay News) -- ... a stethoscope over a main artery to the brain could ... heart disease and stroke, a new study finds. , The ... caused by turbulent blood flow due to buildup of fatty ...
... of Hematology (ASH) is proud to announce the selection ... Award Program (MMSAP), which encourages minority medical students to ... each award recipient will receive the support of a ... to attend medical meetings, and a subscription to the ...
Cached Medicine News:Health News:HealthSouth Board Re-Elected at Annual Shareholder Meeting 2Health News:NutraCea to Host First Quarter 2008 Conference Call on May 12. 2Health News:ALL: More Dead Babies Found in Michigan Dumpsters 2Health News:Bill Moyers' Journal to Feature California Nurses Association/National Nurses Organizing Committee in Friday, May 9th Episode 2Health News:Noise in Artery Could Warn of Heart Risk 2Health News:Minority medical students receive support to increase diversity in hematology 2
Inquire...
... a floor model centrifuge to do, but just ... PR-7000M delivers up to 50% more force in ... faster and more efficiently., Tremendous Capacity ... liters, PR-7000M accommodates 30 microplates, up to 408 ...
Inquire...
Inquire...
Medicine Products: